Hyosung Chemical Corporation
Korea ExchangeTotal Valuation
Hyosung Chemical Corporation carries a market capitalization of 252.46B, placing it among publicly traded companies globally. Its enterprise value stands at 1.84T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 252.46B |
| Enterprise Value | 1.84T |
Share Statistics
Hyosung Chemical Corporation currently has 3.77M shares outstanding.
| Shares Outstanding | 3.77M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Enterprise Valuation
| EV / Sales | 0.78 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 26.69 |
Financial Position
Hyosung Chemical Corporation maintains a current ratio of 0.40, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 249.81, indicating elevated leverage, while an interest coverage ratio of -1.20 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.40 |
| Quick Ratio | 0.02 |
| Debt / Equity | 249.81 |
| Debt / EBITDA | -14.86 |
| Interest Coverage | -1.20 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 0.49 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 7.22 |
Taxes
| Income Tax | -104.87B |
| Effective Tax Rate | N/A |
Stock Price Statistics
Hyosung Chemical Corporation's stock has gained approximately 72.2365% over the past 52 weeks. The 50-day moving average sits at 44,290.00, while the 200-day moving average is 40,247.50.
| Beta (5Y) | N/A |
| 52-Week Price Change | 72.2365% |
| 50-Day Moving Average | 44,290.00 |
| 200-Day Moving Average | 40,247.50 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Hyosung Chemical Corporation generated 2.35T in revenue and converted that into 13.47B in net income, yielding earnings per share of -56,109.95. EBITDA reached -108.12B, while operating income came in at -108.12B.
| Revenue | 2.35T |
| Gross Profit | -24.80B |
| Operating Income | -108.12B |
| Pretax Income | -267.74B |
| Net Income | 13.47B |
| EBITDA | -108.12B |
| EBIT | -108.12B |
| Earnings Per Share (EPS) | -56,109.95 |
Balance Sheet
Hyosung Chemical Corporation holds 31.25B in cash and equivalents against 1.61T in total debt, resulting in a net debt position of 1.56T. Total book value stands at -573.93B, with working capital of -1.00T providing operational flexibility.
| Cash & Cash Equivalents | 31.25B |
| Total Debt | 1.61T |
| Net Debt | 1.56T |
| Equity (Book Value) | -573.93B |
| Book Value Per Share | -197,714.98 |
| Working Capital | -1.00T |
Cash Flow
Hyosung Chemical Corporation produced -96.50B in operating cash flow over the past twelve months. After subtracting -110.51B in capital expenditures, free cash flow totaled -207.01B - equivalent to -71,314.61 per share.
| Operating Cash Flow | -96.50B |
| Capital Expenditures | -110.51B |
| Free Cash Flow | -207.01B |
| FCF Per Share | -71,314.61 |
Margins
Hyosung Chemical Corporation operates with a gross margin of -1.05, reflecting its pricing power and cost economics. The operating margin of -4.59 and net profit margin of 0.57 provide insight into operational efficiency.
| Gross Margin | -1.05 |
| Operating Margin | -4.59 |
| Pretax Margin | -11.37 |
| Profit Margin | 0.57 |
| EBITDA Margin | -4.59 |
Scores
Hyosung Chemical Corporation posts an Altman Z-Score of -0.01, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.01 |